Dawn Bell

Global Head, Strategic Partnerships Team, Novartis

Dawn Bell is Global Development Head, Strategic Partnerships for Novartis, a Top 5 global pharmaceutical company. In this role, she works across the enterprise to increase overall portfolio value by sourcing innovative white-space and grey space opportunities, devising creative external engagement vehicles, and driving a culture of innovation and smart risk-taking to reimagine medicine and improve human health.  Prior to this role, Dawn served as Chief Scientific Officer, Novartis Canada where she oversaw the Pharma portfolio and co-founded the Novartis Canada Biome at Mila.  Dawn has deep knowledge of drug development, reimbursement and commercialization, and has developed and launched more than a dozen innovative medicines. She has a passion for entrepreneurship and start-up communities and is a sought after mentor for start-ups in North America and Europe through her work at University of Toronto’s Creative Destruction Lab and EIT Health’s Gold Track Program. She was Associate of the Year for CDL-Toronto in 2019. She earned her Doctor of Pharmacy degree from the University of Florida and was a tenured professor at West Virginia University before joining industry.